comparemela.com
4
5
6
7
8
9
10
Latest Breaking News On - Douglas miehm - Page 3 : comparemela.com
Friday's analyst upgrades and downgrades - The Globe and Mail
Inside the Market’s roundup of some of today’s key analyst actions
Calgary
Alberta
Canada
Toronto
Ontario
Hong-kong
United-states
American
Canadian
Jonathan-kelcher
Cameron-doerksen
Irene-nattel
Analysts Have Conflicting Sentiments on These Healthcare Companies: AptarGroup (ATR), Halozyme (HALO) and Bausch Health Companies (BHC)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on AptarGroup (ATR – Research Report), Halozyme (HALO – Research.
United-states
America
Douglas-miehm
Avery-dennison
Robert-wasserman
Robertw-baird
Ghansham-panjabi
Silgan-holdings
Aptargroup
Biolife-solutions
Berry-global-group
Integer-holdings
Friday's analyst upgrades and downgrades - The Globe and Mail
Inside the Market’s roundup of some of today’s key analyst actions
Hong-kong
Canada
United-states
Argentina
Brookfield
Nova-scotia
Toronto
Ontario
Montreal
Quebec
America
Canadian
Earnings Preview: What To Expect To When Eye Health Company Bausch + Lomb Reports Q4 Performance Later This Month - Bausch & Lomb (NYSE:BLCO)
"Bausch + Lomb's Q4 & FY 2023 results on Feb 21, 2024. Expecting $1.107 billion in sales, $0.17 EPS. RBC Capital predicts $1.159 billion revenue. Insights on Miebo launch and enhanced EBITDA margins for 2024.
Sahil-dhingra
Xiidra-trx
Alcon-inc
Douglas-miehm
Lomb-corp
Miebo-trxs
Benzinga-pro
Lomb-expands
Care-portfolio
New-drug-application
Earnings Preview: What To Expect To When Eye Health Company Bausch + Lomb Reports Q4 Performance Later This Month
Eye health products company Bausch + Lomb Corp (NYSE:BLCO) is scheduled to release its fourth-quarter and full-year 2023 financial resul.
Xiidra-trx
Douglas-miehm
Sahil-dhingra
Miebo-trxs
Lomb-corp
Alcon-inc
Benzinga-pro
Lomb-expands
Care-portfolio
New-drug-application
vimarsana © 2020. All Rights Reserved.